Canine hypopituitarism is a rare condition characterized by deficiencies in multiple hormones, making accurate diagnosis and consistent management essential. With the right products and care strategies, you can significantly improve your dog’s quality of life.





| Item | Growth Hormone Supplementation | Progestin (Proligestone) | Thyroid Hormone (Levothyroxine) |
|---|---|---|---|
| Main Role | Directly supplements deficient growth hormone | Induces growth hormone production in the mammary glands | Supplements secondary hypothyroidism |
| Expected Effect | Improves growth, quality of life, and survival duration | Avoids antibody formation, normalizes IGF-1 | Supports metabolism and attempts hair growth |
| Administration Method | Veterinarian-prescribed injection | Periodic subcutaneous injection | Oral, veterinarian-prescribed |
| Precautions | Cost burden, risk of antibodies and diabetes | Pyometra, acromegaly, etc. | Dosage determined by the veterinarian |
| Common Points | Veterinarian diagnosis and prescription essential | Veterinarian diagnosis and prescription essential | Veterinarian diagnosis and prescription essential |
All treatments are safest when performed after receiving a veterinarian's diagnosis and prescription.
Precautions and Contraindications
Please use products for managing canine hypopituitarism only under veterinary guidance. Overdosing can worsen hormonal imbalances. In particular, if your dog has underlying health conditions, there may be interactions with other medications, so it is essential to consult with your veterinarian.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Giger, U. and Gorman, N.T. (1984). Oncologic emergencies in small animals. Veterinary Clinics of North America: Small Animal Practice, 14(1), 1–15.
[2] Barrot, A.C., Bedard, A., and Dunn, M. (2017). Syndrome of inappropriate antidiuretic hormone secretion in a dog with a histiocytic sarcoma. Canadian Veterinary Journal, 58(7), 713–715.
[3] Miell, J., Dhanjal, P., and Jamookeeah, C. (2015). Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review. International Journal of Clinical Practice, 69(12), 1396–1417.